Insulet
PODD
#2028
Rank
NZ$17.31 B
Marketcap
NZ$249.62
Share price
-1.96%
Change (1 day)
-57.64%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$10.41

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$10.80. In 2024 the company made an earnings per share (EPS) of NZ$10.88 an increase over its 2023 EPS that were of NZ$5.37.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$10.41
2024NZ$10.88102.71%
2023NZ$5.374114.29%
2022NZ$0.13-69.57%
2021NZ$0.42109.09%
2020NZ$0.20-38.89%
2019NZ$0.33200%
2018NZ$0.11-113.04%
2017NZ-$0.84-9.8%
2016NZ-$0.93-60.47%
2015NZ-$2.3538.71%
2014NZ-$1.6912.05%
2013NZ-$1.51-23.15%
2012NZ-$1.96-12.2%
2011NZ-$2.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.15 12.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.92-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.42-31.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$56.19 420.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$1.69-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$2.18-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.71-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA